Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 3Genitourinary 1

Conditions

Peritoneal Neoplasms 1Ovarian Cysts 1Hemorrhage 1Gynecologic Cancer 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × FloSeal Matrix × Clear all
NCT07232927 2025-11-18

HEMOSTA-PN

Ankara University

Phase NA Completed
150 enrolled
Genitourinary

Carcinoma, Renal Cell, Hemorrhage

NCT01957852 2015-02-25

FloSeal in CRS and HIPEC

Maisonneuve-Rosemont Hospital

Completed
86 enrolled
Gynecologic

Peritoneal Neoplasms

NCT01974193 2015-02-11

Prevention of Pelvic Lymphocele by Floseal During Pelvic Lymphadenectomy for Gynecologic Cancer

Ewha Womans University Mokdong Hospital

Phase 3 Unknown
40 enrolled
Gynecologic

Gynecologic Cancer

NCT01857466 2014-06-25

Ovarian Reserve After Ovarian Hemostasis by Floseal Matrix

CHA University

Phase 3 Completed
100 enrolled
Gynecologic

Ovarian Cysts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡